Commercialization
Developing and Commercializing Rare Disease Drugs: Navigating Uncharted Territory
Pharmaceutical companies developing and commercializing rare disease drugs face unique challenges. However, clinical and ...
Why the Patient Voice Should Influence Drug Development—and How It Can
Big Tech companies have mastered the consumer experience, enabling the likes of Apple, Google, ...
How COVID Has Reshaped the Clinical Trial Regulatory Landscape
The concept of patient centricity is hardly new, but in recent months it has ...
Can Biogen’s Aduhelm Be Effective in Treatment of Alzheimer’s Despite the Controversy Surrounding its Approval?
When the FDA approved Biogen’s Aduhelm (aducanumab) in early June, it was the first ...
How COVID-19 Strengthened the Supply Chain and Key Takeaways for the Future
March 11, 2021 marked one year since the coronavirus was declared a global pandemic ...
Clene is Using Nanocrystals of Pure Elements to Change Neurodegenerative Treatment
As our brains age, our neurons shrink and lose energy making it harder for ...
2021: A “Tale of Two Cities” for the Pharma Industry
Uncertainty was the prevailing theme of 2020 across nearly every sector and business function ...
Defining Success In 2020: What COVID Has and Hasn’t Changed
It’s an understatement that the world as we know it now is different than ...
Transforming the Clinical Trial Experience with Mobile Research Nursing
Following the emergence of the novel coronavirus, more than 1,000 clinical trials for non-COVID-19 ...
Vineti Is Streamlining the Supply Chain for Personalized Therapies
Personalized medicine—such as cell and gene therapies (CGT) and personalized cancer vaccines—are completely changing ...
Expect Amazon to Accelerate its Healthcare Positioning in Three Key Areas
In September 2019, we discussed the definition and impact of the “Amazon Effect” in ...
Can Real-World Evidence Help Eliminate Racial Disparities in Clinical Research?
In a bold update made at the beginning of 2020, the Institute for Clinical ...
Get in the Game: Why Biopharma Should Embrace Digital Therapeutics
Can software really treat disease? Until recently, many in healthcare would have viewed this ...
